Terms: = Skin cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
4 results:
1. Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.
Zakria D; Brownstone N; Berman B; Ceilley R; Cronin TA; Del Rosso JQ; Ferris LK; Goldenberg G; Siegel D
J Drugs Dermatol; 2024 Feb; 23(2):54-60. PubMed ID: 38306124
[TBL] [Abstract] [Full Text] [Related]
2. Chelerythrine Chloride Inhibits Stemness of Melanoma cancer Stem-Like Cells (CSCs) Potentially via Inducing Reactive Oxygen Species and Causing Mitochondria Dysfunction.
Li H; He M; Zhao P; Liu P; Chen W; Xu X
Comput Math Methods Med; 2022; 2022():4000733. PubMed ID: 35761835
[TBL] [Abstract] [Full Text] [Related]
3. Expression of the cancer stem cell marker oct4 is associated with worse prognosis and survival in cutaneous melanoma.
Silva CTX; Saddi VA; Silva KSFE; Sugita DM; Guillo LA
Melanoma Res; 2021 Oct; 31(5):439-448. PubMed ID: 34433195
[TBL] [Abstract] [Full Text] [Related]
4. Nanog and oct4 overexpression increases motility and transmigration of melanoma cells.
Borrull A; Ghislin S; Deshayes F; Lauriol J; Alcaide-Loridan C; Middendorp S
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1145-54. PubMed ID: 22406932
[TBL] [Abstract] [Full Text] [Related]
